89 results on '"Tannous M"'
Search Results
2. Evaluating the Robustness of Autonomous Inspections in the Energy Industry with a Quadruped Robot
- Author
-
Fiorucci, M., additional, Schillaci, G., additional, Tannous, M., additional, Bianchi, L., additional, Salusti, L., additional, Cioncolini, S., additional, Politano, A., additional, and De Magistris, G., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Cyclic nigerosyl-1,6-nigerose-based nanosponges: An innovative pH and time-controlled nanocarrier for improving cancer treatment
- Author
-
Caldera, F., Argenziano, M., Trotta, F., Dianzani, C., Gigliotti, L., Tannous, M., Pastero, L., Aquilano, D., Nishimoto, T., Higashiyama, T., and Cavalli, R.
- Published
- 2018
- Full Text
- View/download PDF
4. P07-17 Recommendation of health-based biological guidance value for aluminium and its inorganic compounds for workers and the general population
- Author
-
Darney, K., Tannous, M., Belzunces, L., Nikolova-Pavageau, N., Schroeder, H., Ndaw, S., and Garnier, R.
- Published
- 2024
- Full Text
- View/download PDF
5. Legionella pneumonia: experience in a community teaching hospital
- Author
-
Okoye, O., Tannous, M., Shekar, R., and Ravakhah, K.
- Published
- 2004
- Full Text
- View/download PDF
6. 133 The activity of metabolic enzymes in bovine oocytes derived from ovaries with heterogenous physiological conditions
- Author
-
Gebremedhn, S., primary, Ambrogi, M., additional, Krueger, B., additional, Natera, E., additional, Tannous, M., additional, Clark, K., additional, Rajput, S., additional, Krisher, R. L., additional, and Rubessa, M., additional
- Published
- 2021
- Full Text
- View/download PDF
7. 132 Abundance and activity of metabolic enzymes in bovine cumulus cells derived from ovarian samples under variable physiological conditions
- Author
-
Gebremedhn, S., primary, Tannous, M., additional, Natera, E., additional, Krueger, B., additional, Ambrogi, M., additional, Clark, K., additional, Rajput, S., additional, Krisher, R. L., additional, and Rubessa, M., additional
- Published
- 2021
- Full Text
- View/download PDF
8. Functional inactivation by interleukin-1β of glyceraldehyde-3-phosphate dehydrogenase in insulin-secreting cells
- Author
-
Veluthakal, R., Khan, I., Tannous, M., and Kowluru, A.
- Published
- 2002
- Full Text
- View/download PDF
9. Evidence for iNOS-dependent peroxynitrite production in diabetic platelets
- Author
-
Tannous, M., Rabini, R. A., Vignini, A., Moretti, N., Fumelli, P., Zielinski, B., Mazzanti, L., and Mutus, B.
- Published
- 1999
- Full Text
- View/download PDF
10. Use of tacrolimus in the treatment of autoimmune hepatitis: a single centre experience
- Author
-
Tannous, M. M., Cheng, J., Muniyappa, K., Farooq, I., Bharara, A., Kappus, M., Luketic, V., Stravtiz, R. T., Fuchs, M., Puri, P., Sanyal, A., and Sterling, R.
- Published
- 2011
- Full Text
- View/download PDF
11. Violences polymorphes conjugees au feminin pluriel : Briser le couple silence-impuissance
- Author
-
Tannous, M.-R and Tannous, M.-R
- Abstract
Si la violence faite aux femmes a traverse des siecles, des civilisations et des continents, il serait important de decouvrir les elements qui l'ont nourrie et ont participe a sa perpetuation. Ce collectif a voulu analyser la participation de plusieurs elements a l'accroissement et a la multiplication des formes de manifestation de la violence faite aux femmes. Il s'est arrete aux implications qu'inflige la violence, sous ses differentes formes, a la femme aux niveaux psychologique, social, physique, sexuel, economique et spirituel. Il s'est attarde sur les possibilites d'aide et de soutien a offrir aux femmes sujettes a la violence. Il souhaite participer a une meilleure reconnaissance de la place de la femme dans nos societes. Il ne vise pas a creer ou a renforcer une segregation entre la femme et l'homme; bien au contraire, il plaide pour une prise de conscience de l'importance de la collaboration entre les deux sexes pour faire du monde un atelier ou homme et femme sculptent chacun sa propre vie tout en tenant compte de la place de l'autre, de ses competences et de ses specificites.
- Published
- 2021
12. State-Dependent Riccati Equation Control for Spacecraft Formation flying in the Circular Restricted Three-Body Problem
- Author
-
Tannous, M., Franzini, G., and Innocenti, M.
- Published
- 2018
13. Spacecraft relative motion control using the state-dependent Riccati equation technique
- Author
-
Tannous, M., Innocenti, Mario, and Franzini, Giovanni
- Published
- 2017
14. Expérience de suivi de l’alcoolo-dépendance en Corse du Sud : exemple du baclofène
- Author
-
Néant, N., primary, Tannous, M., additional, Massa, F., additional, Van Cappel de Premont, C., additional, Orabona, V., additional, and Grassi, J., additional
- Published
- 2017
- Full Text
- View/download PDF
15. CP-021 Clinical experience with baclofen in alcohol dependence treatment
- Author
-
Néant, N, primary, Massa, F, additional, Tannous, M, additional, Van Cappel De Premont, C, additional, Orabona, V, additional, and Grassi, J, additional
- Published
- 2017
- Full Text
- View/download PDF
16. Cytotoxic Activities of Mannich Bases of Chalcones and Related Compounds
- Author
-
Balzarini J, Sudom Am, Timothy G. Myers, Dimmock, De Clercq E, Halleran S, Quail Jw, Bulent Mutus, Rose P, M. Chamankhah, Allen Tm, Pugazhenthi U, Szydlowski J, Pass E, Hetherington M, Tannous M, Kandepu Nm, and Elias K. Manavathu
- Subjects
Chalcone ,Tertiary amine ,Stereochemistry ,T-Lymphocytes ,Antineoplastic Agents ,Mannich base ,Crystallography, X-Ray ,Chemical synthesis ,Mannich Bases ,Mice ,Structure-Activity Relationship ,chemistry.chemical_compound ,Drug Discovery ,Tumor Cells, Cultured ,Animals ,Humans ,Structure–activity relationship ,Leukemia L1210 ,Cytotoxicity ,Leukemia P388 ,Glutathione ,chemistry ,Biochemistry ,Molecular Medicine ,L1210 cells ,Drug Screening Assays, Antitumor ,Cell Division - Abstract
Various Mannich bases of chalcones and related compounds displayed significant cytotoxicity toward murine P388 and L1210 leukemia cells as well as a number of human tumor cell lines. The most promising lead molecule was 21 that had the highest activity toward L1210 and human tumor cells. In addition, 21 exerted preferential toxicity to human tumor lines compared to transformed human T-lymphocytes. Other compounds of interest were 38, with a huge differential in cytotoxicity between P388 and L1210 cells, and 42, with a high therapeutic index when cytotoxicity to P388 cells and Molt 4/C8 T-lymphocytes were compared. In general, the Mannich bases were more cytotoxic than the corresponding chalcones toward L1210 but not P388 cells. A ClusCor analysis of the data obtained from the in vitro human tumor screen revealed that the mode of action of certain groups of compounds was similar. For some groups of compounds, cytotoxicity was correlated with the sigma, pi, or molar refractivity constants in the aryl ring attached to the olefinic group. In addition, the IC50 values in all three screens correlated with the redox potentials of a number of Mannich bases. X-ray crystallography and molecular modeling of representative compounds revealed various structural features which were considered to contribute to cytotoxicity. While a representative compound 15 was stable and unreactive toward glutathione (GSH) in buffer, the Mannich bases 15, 18, and 21 reacted with GSH in the presence of the pi isozyme of glutathione S-transferase, suggesting that thiol alkylation may be one mechanism by which cytotoxicity was exerted in vitro. Representative compounds were shown to be nonmutagenic in an intrachromosomal recombination assay in yeast, devoid of antimicrobial properties and possessing anticonvulsant and neurotoxic properties. Thus Mannich bases of chalcones represent a new group of cytotoxic agents of which 21 in particular serves as an useful prototypic molecule.
- Published
- 1998
- Full Text
- View/download PDF
17. Multiplex blood reporters for simultaneous monitoring of cellular processes
- Author
-
Bovenberg, M.S., Degeling, M.H., Hejazi, S., Amante, R.J., Keulen, M. van, Jeuken, J.W.M., Akbaripanahi, S., Vleggeert-Lankamp, C.L., Tannous, M., Wesseling, P., Wurdinger, T., Tannous, B.A., Bovenberg, M.S., Degeling, M.H., Hejazi, S., Amante, R.J., Keulen, M. van, Jeuken, J.W.M., Akbaripanahi, S., Vleggeert-Lankamp, C.L., Tannous, M., Wesseling, P., Wurdinger, T., and Tannous, B.A.
- Abstract
Contains fulltext : 125685.pdf (publisher's version ) (Open Access), Reporters secreted into the conditioned medium of cells in culture or into blood in vivo have shown to be useful tools for simple and noninvasive monitoring of biological processes in real-time. Here, we characterize the naturally secreted Vargula luciferase as a secreted blood reporter and show that this reporter can be multiplexed with the secreted Gaussia luciferase and alkaline phosphatase for simultaneous monitoring of three different cellular processes in the same biological system. We applied this system to monitor the response of three different subsets of glioma cells to a clinically relevant chemotherapeutic agent in the same well in culture or animal in vivo. This system could be extended to any field to detect multiple processes in the same biological system and is amenable for high-throughput screening to find drugs that affect multiple cellular populations/phenomena simultaneously.
- Published
- 2013
18. 148 PROTON PUMP INHIBITOR USE IS ASSOCIATED WITH THE DEVELOPMENT OF A BROAD RANGE OF INFECTIONS IN CIRRHOSIS
- Author
-
Bajaj, J.S., primary, Tannous, M., additional, Bootwala, Z., additional, Sanyal, A.J., additional, and Heuman, D.M., additional
- Published
- 2010
- Full Text
- View/download PDF
19. Cytotoxic Activities of Mannich Bases of Chalcones and Related Compounds
- Author
-
Dimmock, J. R., Kandepu, N. M., Hetherington, M., Quail, J. W., Pugazhenthi, U., Sudom, A. M., Chamankhah, M., Rose, P., Pass, E., Allen, T. M., Halleran, S., Szydlowski, J., Mutus, B., Tannous, M., Manavathu, E. K., Myers, T. G., Clercq, E De, and Balzarini, J.
- Abstract
Various Mannich bases of chalcones and related compounds displayed significant cytotoxicity toward murine P388 and L1210 leukemia cells as well as a number of human tumor cell lines. The most promising lead molecule was
21 that had the highest activity toward L1210 and human tumor cells. In addition,21 exerted preferential toxicity to human tumor lines compared to transformed human T-lymphocytes. Other compounds of interest were38 , with a huge differential in cytotoxicity between P388 and L1210 cells, and42 , with a high therapeutic index when cytotoxicity to P388 cells and Molt 4/C8 T-lymphocytes were compared. In general, the Mannich bases were more cytotoxic than the corresponding chalcones toward L1210 but not P388 cells. A ClusCor analysis of the data obtained from the in vitro human tumor screen revealed that the mode of action of certain groups of compounds was similar. For some groups of compounds, cytotoxicity was correlated with the σ, π, or molar refractivity constants in the aryl ring attached to the olefinic group. In addition, the IC50 values in all three screens correlated with the redox potentials of a number of Mannich bases. X-ray crystallography and molecular modeling of representative compounds revealed various structural features which were considered to contribute to cytotoxicity. While a representative compound15 was stable and unreactive toward glutathione (GSH) in buffer, the Mannich bases15 ,18 , and21 reacted with GSH in the presence of the π isozyme of glutathione S-transferase, suggesting that thiol alkylation may be one mechanism by which cytotoxicity was exerted in vitro. Representative compounds were shown to be nonmutagenic in an intrachromosomal recombination assay in yeast, devoid of antimicrobial properties and possessing anticonvulsant and neurotoxic properties. Thus Mannich bases of chalcones represent a new group of cytotoxic agents of which21 in particular serves as an useful prototypic molecule.- Published
- 1998
20. A photo-activated, protein-based, NO/H~2O~2 generating system with tumoricidal activity composed of the nitric oxide derivative of apo-metallothionein (thionein-NO) and glucose oxidase
- Author
-
Tannous, M., Labbe, N., Redmond, R. W., and Mutus, B.
- Published
- 1997
- Full Text
- View/download PDF
21. ELISA for In Vivo Assessment of Nonenzymatically Glycated Platelet Glutathione Peroxidase
- Author
-
Muruganandam, A., Tannous, M., and Mutus, B.
- Published
- 1994
- Full Text
- View/download PDF
22. Effects of therapeutic touch on biochemical and mood indicators in women.
- Author
-
Lafreniere, K.D., Mutus, B., Cameron, S., Tannous, M., Giannotti, M., Abu-Zahra, H., and Laukkanen, E.
- Subjects
- *
BIOMARKERS , *MOOD (Psychology) , *PERSONALITY tests , *THERAPEUTICS , *PHYSIOLOGY - Abstract
Evaluates the effect of therapeutic touch on biochemical indicators and moods in a sample of healthy female volunteers. Collection of pretest and posttest urine samples; Administration of personality and mood inventories; Analyses of biochemical data.
- Published
- 2000
23. Gas-loaded nanocarriers to improve cardioprotection by cardioplegic solution.
- Author
-
Rubeo C, Giordano M, Tannous M, Duràn AM, Comità S, Landolfi V, Aragno M, Cavalli R, Penna C, Trotta F, and Pagliaro P
- Subjects
- Animals, Nanoparticles, Drug Carriers, Heart Arrest, Induced adverse effects, Heart Arrest, Induced methods, Gases, Humans, Disease Models, Animal, Myocardial Infarction prevention & control, Myocardial Infarction metabolism, Myocardial Infarction drug therapy, Cardiotonic Agents pharmacology, Cardiotonic Agents administration & dosage, Cardioplegic Solutions administration & dosage, Cardioplegic Solutions pharmacology, Myocardial Reperfusion Injury prevention & control, Myocardial Reperfusion Injury metabolism, Myocardial Reperfusion Injury pathology, Myocardial Reperfusion Injury physiopathology
- Published
- 2024
- Full Text
- View/download PDF
24. Air-soil cycling of oxygenated, nitrated and parent polycyclic aromatic hydrocarbons in source and receptor areas.
- Author
-
Mwangi JK, Degrendele C, Bandowe BAM, Bohlin-Nizzetto P, Halse AK, Šmejkalová AH, Kim JT, Kukučka P, Martiník J, Nežiková BP, Přibylová P, Prokeš R, Sáňka M, Tannous M, Vinkler J, and Lammel G
- Abstract
Polycyclic aromatic hydrocarbons (PAHs) and their oxygenated and nitrated derivatives, OPAHs and NPAHs, are semivolatile air pollutants which are distributed and cycling regionally. Subsequent to atmospheric deposition to and accumulation in soils they may re-volatilise, a secondary source which is understudied. We studied the direction of air-soil mass exchange fluxes of 12 OPAHs, 17 NPAHs, 25 PAHs and one alkylated PAH in two rural environments being influenced by the pollutant concentrations in soil and air, by season, and by land cover. The OPAHs and NPAHs in samples of topsoil, of ambient air particulate and gas phases and in the gas-phase equilibrated with soil were analysed by GC-APCI-MS/MS. The pollutants soil burdens show a pronounced seasonality, a winter maximum for NPAHs and PAHs and a summer maximum for OPAHs. One order of magnitude more OPAH and parent PAH are found stored in forest soil than in nearby grassland soil. Among a number of 3-4 ring PAHs, the OPAHs benzanthrone and 6H-benzo(c,d)pyren-6-one, and the NPAHs 1- and 2-nitronaphthalene, 9-nitrophenanthrene and 7-nitrobenz(a)anthracene are found to re-volatilise from soils at a rural background site in central Europe in summer. At a receptor site in northern Europe, net deposition of polycyclic aromatic compounds (PACs) prevails and re-volatilisation occurs only sporadic. Re-volatilisation of a number of PACs, including strong mutagens, from soils in summer and even in winter indicates that long-range atmospheric transport of primary PAC emissions from central Europe to receptor areas might be enhanced by secondary emissions from soils., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
25. Current Status and Trends in Nucleic Acids for Cancer Therapy: A Focus on Polysaccharide-Based Nanomedicines.
- Author
-
Molinar C, Tannous M, Meloni D, Cavalli R, and Scomparin A
- Subjects
- Humans, Nanomedicine, COVID-19 Vaccines, Polysaccharides therapeutic use, Polysaccharides chemistry, Polymers chemistry, Carbohydrates, Sugars, Nucleic Acids therapeutic use, Nucleic Acids chemistry, COVID-19, Nanoparticles therapeutic use, Nanoparticles chemistry, Neoplasms drug therapy, Neoplasms genetics
- Abstract
The efficacious delivery of therapeutic nucleic acids to cancer still remains an open issue. Through the years, several strategies are developed for the encapsulation of genetic molecules exploiting different materials, such as viral vectors, lipid nanoparticles (LNPs), and polymeric nanoparticles (NPs). Indeed, the rapid approval by regulatory authorities and the wide use of LNPs complexing the mRNA coding for the spark protein for COVID-19 vaccination paved the way for the initiation of several clinical trials exploiting lipid nanoparticles for cancer therapy. Nevertheless, polymers still represent a valuable alternative to lipid-based formulations, due to the low cost and the chemical flexibility that allows for the conjugation of targeting ligands. This review will analyze the status of the ongoing clinical trials for cancer therapy, including vaccination and immunotherapy approaches, exploiting polymeric materials. Among those nanosized carriers, sugar-based backbones are an interesting category. A cyclodextrin-based carrier (CALAA-01) is the first polymeric material to enter a clinical trial complexed with siRNA for cancer therapy, and chitosan is one of the most characterized non-viral vectors able to complex genetic material. Finally, the recent advances in the use of sugar-based polymers (oligo- and polysaccharides) for the complexation of nucleic acids in advanced preclinical stage will be discussed., (© 2023 The Authors. Macromolecular Bioscience published by Wiley-VCH GmbH.)
- Published
- 2023
- Full Text
- View/download PDF
26. Oxygen Nanocarriers for Improving Cardioplegic Solution Performance: Physico-Chemical Characterization.
- Author
-
Tannous M, Hoti G, Trotta F, Cavalli R, Higashiyama T, Pagliaro P, and Penna C
- Subjects
- Humans, Oxygen pharmacology, Heart, Myocardium, Cardioplegic Solutions pharmacology, Cardioplegic Solutions therapeutic use, Heart Arrest drug therapy
- Abstract
Nanocarriers for oxygen delivery have been the focus of extensive research to ameliorate the therapeutic effects of current anti-cancer treatments and in the organ transplant field. In the latter application, the use of oxygenated cardioplegic solution (CS) during cardiac arrest is certainly beneficial, and fully oxygenated crystalloid solutions may be excellent means of myocardial protection, albeit for a limited time. Therefore, to overcome this drawback, oxygenated nanosponges (NSs) that can store and slowly release oxygen over a controlled period have been chosen as nanocarriers to enhance the functionality of cardioplegic solutions. Different components can be used to prepare nanocarrier formulations for saturated oxygen delivery, and these include native α-cyclodextrin (αCD), αcyclodextrin-based nanosponges (αCD-NSs), native cyclic nigerosyl-nigerose (CNN), and cyclic nigerosyl-nigerose-based nanosponges (CNN-NSs). Oxygen release kinetics varied depending on the nanocarrier used, demonstrating higher oxygen release after 24 h for NSs than the native αCD and CNN. CNN-NSs presented the highest oxygen concentration (8.57 mg/L) in the National Institutes of Health (NIH) CS recorded at 37 °C for 12 h. The NSs retained more oxygen at 1.30 g/L than 0.13 g/L. These nanocarriers have considerable versatility and the ability to store oxygen and prolong the amount of time that the heart remains in hypothermic CS. The physicochemical characterization presents a promising oxygen-carrier formulation that can prolong the release of oxygen at low temperatures. This can make the nanocarriers suitable for the storage of hearts during the explant and transport procedure.
- Published
- 2023
- Full Text
- View/download PDF
27. A Deep-Learning-Based Detection Approach for the Identification of Insect Species of Economic Importance.
- Author
-
Tannous M, Stefanini C, and Romano D
- Abstract
Artificial Intelligence (AI) and automation are fostering more sustainable and effective solutions for a wide spectrum of agricultural problems. Pest management is a major challenge for crop production that can benefit from machine learning techniques to detect and monitor specific pests and diseases. Traditional monitoring is labor intensive, time demanding, and expensive, while machine learning paradigms may support cost-effective crop protection decisions. However, previous studies mainly relied on morphological images of stationary or immobilized animals. Other features related to living animals behaving in the environment (e.g., walking trajectories, different postures, etc.) have been overlooked so far. In this study, we developed a detection method based on convolutional neural network (CNN) that can accurately classify in real-time two tephritid species ( Ceratitis capitata and Bactrocera oleae ) free to move and change their posture. Results showed a successful automatic detection (i.e., precision rate about 93%) in real-time of C. capitata and B. oleae adults using a camera sensor at a fixed height. In addition, the similar shape and movement patterns of the two insects did not interfere with the network precision. The proposed method can be extended to other pest species, needing minimal data pre-processing and similar architecture.
- Published
- 2023
- Full Text
- View/download PDF
28. Dextrin-Based Nanohydrogels for Rokitamycin Prolonged Topical Delivery.
- Author
-
Tannous M, Lucia Appleton S, Hoti G, Caldera F, Argenziano M, Monfared YK, Matencio A, Trotta F, and Cavalli R
- Abstract
Macrolides are widely used antibiotics with a broad spectrum of activity. The development of drug carriers to deliver this type of antibiotics has attracted much research. The present study aims at developing new swellable dextrin-based nanohydrogels for the topical delivery of rokitamycin, as model macrolide. Rokitamycin is a synthetic analogous of macrolides with advantageous characteristics as far as bacterial uptake and post-antibiotic effect are concerned. It is also indicated for the treatment of severe infections caused by Acanthamoeba and for topical infections. The nanohydrogels have been prepared from two types of cross-linked polymers obtained by using β-cyclodextrin or Linecaps
® was provided by the Roquette Italia SPA (Cassano Spinola, Al, Italy) as building blocks. The cross-linked polymers have been then formulated into aqueous nanosuspensions refined and tuned to achieve the incorporation of the drug. Cross-linked β-cyclodextrin (β-CD) and Linecaps® (LC) polymers formed dextrin-based nanohydrogels with high swelling degree and mucoadhesion capability. Rokitamycin was loaded into the nanohydrogels displaying an average size around 200 nm with negative surface charge. In vitro kinetic profiles of free and loaded drug in nanohydrogels were compared at two pH levels. Interestingly, a sustained and controlled release was obtained at skin pH level due to the high degree of swelling and a pH responsiveness possibly. The results collected suggest that these nanohydrogels are promising for the delivery of rokitamycin and may pave the way for the topical delivery of other macrolide antibiotics.- Published
- 2022
- Full Text
- View/download PDF
29. Impacts of the COVID-19 pandemic on elective cataract surgeries.
- Author
-
Tannous M, Mendes RLF, Freitas AVC, Magalhães AM, Ferrari R, Miolo BL, Alves MR, Avakian A, and Carricondo PC
- Subjects
- Cross-Sectional Studies, Humans, Pandemics prevention & control, SARS-CoV-2, COVID-19, Cataract epidemiology
- Abstract
Objective: To evaluate the standards of practice of Brazilian cataract surgeons in relation to the protective measures adopted to mitigate the risks of transmission of COVID-19 during cataract surgery, in asymptomatic patients., Methods: A descriptive, cross-sectional, quantitative paradigm study, developed from a self-administered electronic questionnaire sent to ophthalmologists and residents/specialists in ophthalmology in Brazil, who performed cataract surgeries in 2019 and 2020, connected through social media and mail listing from local societies., Results: Of the 303 participating surgeons, 159 (n=52.2%) performed elective cataract surgeries between March 20th, 2020 to June 1st, 2020. Among the measures adopted by ophthalmologists with the purpose of preventing viral transmission, the patient's temperature was measured by 84.3% (n=134), and the verification of respiratory symptoms and contact/exposure to cases of COVID-19 by 87.4% (n=139). Most did not submit their patients to laboratory tests to detect COVID-19 (145; 91.2%). In surgery, 44.7% (n=71) used an N95 mask, and 69.2% (n=110) kept their patients with a mask. No stage of phacoemulsification was modified in 144 (90.6%) participants, 13 (8.2%) added methylcellulose under the main incision, and two (1.3%), modified another surgical stage., Conclusion: The COVID-19 pandemic significantly interrupted part of cataract surgeries in Brazil from March to June 2020 and measures to prevent viral spread are being heterogeneously adopted by surgeons. Understanding these measures could be the first step to improve strategies to return to pre-pandemic levels.
- Published
- 2022
- Full Text
- View/download PDF
30. 132 Abundance and activity of metabolic enzymes in bovine cumulus cells derived from ovarian samples under variable physiological conditions.
- Author
-
Gebremedhn S, Tannous M, Natera E, Krueger B, Ambrogi M, Clark K, Rajput S, Krisher RL, and Rubessa M
- Published
- 2021
- Full Text
- View/download PDF
31. 133 The activity of metabolic enzymes in bovine oocytes derived from ovaries with heterogenous physiological conditions.
- Author
-
Gebremedhn S, Ambrogi M, Krueger B, Natera E, Tannous M, Clark K, Rajput S, Krisher RL, and Rubessa M
- Published
- 2021
- Full Text
- View/download PDF
32. Drug-Encapsulated Cyclodextrin Nanosponges.
- Author
-
Tannous M, Caldera F, Hoti G, Dianzani U, Cavalli R, and Trotta F
- Subjects
- Cyclodextrins therapeutic use, Drug Carriers therapeutic use, Nanoparticles therapeutic use, Cyclodextrins chemistry, Drug Carriers chemistry, Nanoparticles chemistry
- Abstract
To date, a number of nanocarriers, either inorganic or organic, have been developed to improve the delivery and therapeutic efficacy of various drugs. Drug delivery systems have attempted to overcome the undesirable pharmacokinetic problems encountered. Among the various nanomaterials that have been designed as potential nanocarriers, cyclodextrin-based polymers are of particular interest in this review.Cyclodextrins (CD) are a class of cyclic glucopyranose oligomers, obtained from starch by enzymatic action, with a characteristic toroidal shape that forms a truncated cone-shaped lipophilic cavity. The main common native cyclodextrins are named α, β, and γ which comprise six, seven, and eight glucopyranose units, respectively. Cyclodextrins have the capability to include compounds whose size and polarity are compatible with those of their cavity.Cyclodextrin-based cross-linked polymers, often referred to as "cyclodextrin nanosponges" (CDNSs), attract great attention from researchers for solving major bioavailability problems such as inadequate solubility, poor dissolution rate, and limited stability of some agents, as well as increasing their effectiveness and decreasing unwanted side effects.Registered patents about this novel system in various fields, different pharmaceutical applications, and classes of drugs encapsulated by CDNSs are detailed. The features outlined make CDNSs a promising platform for the development of innovative and advanced delivery systems.
- Published
- 2021
- Full Text
- View/download PDF
33. Corrigendum to: Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.
- Author
-
Teng J, Hejazi S, Hiddingh L, Carvalho L, de Gooijer M, Wakimoto H, Barazas M, Tannous M, Chi AS, Noske DP, Wesseling P, Wurdinger T, Batchelor TT, and Tannous BA
- Published
- 2020
- Full Text
- View/download PDF
34. Nanosponges as protein delivery systems: Insulin, a case study.
- Author
-
Appleton SL, Tannous M, Argenziano M, Muntoni E, Rosa AC, Rossi D, Caldera F, Scomparin A, Trotta F, and Cavalli R
- Subjects
- Administration, Oral, Animals, Caco-2 Cells, Drug Carriers, Drug Delivery Systems, Humans, Insulin, Mice, Rats, Cyclodextrins, Diabetes Mellitus, Experimental drug therapy
- Abstract
Cyclodextrin-based nanosponges have been found to bepromising drug delivery systems. This paper investigates an application that still needs to be studied in depth, that is, the oral delivery of peptides and proteins, choosing insulin as a case study. The nanospongewas synthesized by crosslinkingβ-cyclodextrins withpyromellitic dianhydride, adopting a top-down approach for its subsequent formulation. Aphysicochemical characterization, in-vitro andin-vivo tests were carried out on the formulation developed. It was nanometric (around 250 nm) with high negative zeta potential, mucoadhesion and swelling properties, good loading capability (about 14%) and encapsulation efficiency (above 90%). The in-vitro release of insulin was negligible at a gastric pH (below 2%) while sustained at an intestinal pH, thus showing a pH-sensitive behaviour of the nanosponge. The Caco-2 cell permeability assay proved that the intestinal permeation of insulin was enhanced when loaded inside the nanosponge. The in-vivo studies confirmed the presence of insulin in rat plasma and a marked hypoglycemic effect in diabetic mice after duodenal and oral administrations, respectively. These preliminary results are encouraging with a view to continuing to study this β-cyclodextrin nanosponge technology for the oral administration of insulin and extending this approach to other proteins of pharmaceutical interest., (Copyright © 2020 Elsevier B.V. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
35. Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122.
- Author
-
Chai C, Cox B, Yaish D, Gross D, Rosenberg N, Amblard F, Shemuelian Z, Gefen M, Korach A, Tirosh O, Lanton T, Link H, Tam J, Permyakova A, Ozhan G, Citrin J, Liao H, Tannous M, Hahn M, Axelrod J, Arretxe E, Alonso C, Martinez-Arranz I, Betés PO, Safadi R, Salhab A, Amer J, Tber Z, Mengshetti S, Giladi H, Schinazi RF, and Galun E
- Subjects
- Animals, Antagomirs administration & dosage, Benzamides pharmacology, Benzamides therapeutic use, Body Weight, Cell Line, Tumor, Datasets as Topic, Diet, High-Fat adverse effects, Disease Models, Animal, Fatty Acids, Nonesterified blood, Fatty Acids, Nonesterified metabolism, Humans, Insulin Resistance, Lipid Metabolism drug effects, Lipid Metabolism genetics, Lipid Regulating Agents therapeutic use, Liver drug effects, Liver pathology, Male, Mice, MicroRNAs antagonists & inhibitors, MicroRNAs blood, Mutation, Non-alcoholic Fatty Liver Disease etiology, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease pathology, Nuclear Receptor Subfamily 1, Group F, Member 1 metabolism, Obesity etiology, Obesity metabolism, Obesity pathology, Promoter Regions, Genetic drug effects, Up-Regulation drug effects, Lipid Regulating Agents pharmacology, MicroRNAs genetics, Non-alcoholic Fatty Liver Disease drug therapy, Nuclear Receptor Subfamily 1, Group F, Member 1 agonists, Obesity drug therapy
- Abstract
Background & Aims: Development of nonalcoholic steatohepatitis (NASH) is associated with reductions in hepatic microRNA122 (MIR122); the RAR related orphan receptor A (RORA) promotes expression of MIR122. Increasing expression of RORA in livers of mice increases expression of MIR122 and reduces lipotoxicity. We investigated the effects of a RORA agonist in mouse models of NASH., Methods: We screened a chemical library to identify agonists of RORA and tested their effects on a human hepatocellular carcinoma cell line (Huh7). C57BL/6 mice were fed a chow or high-fat diet (HFD) for 4 weeks to induce fatty liver. Mice were given hydrodynamic tail vein injections of a MIR122 antagonist (antagomiR-122) or a control antagomiR once each week for 3 weeks while still on the HFD or chow diet, or intraperitoneal injections of the RORA agonist RS-2982 or vehicle, twice each week for 3 weeks. Livers, gonad white adipose, and skeletal muscle were collected and analyzed by reverse-transcription polymerase chain reaction, histology, and immunohistochemistry. A separate group of mice were fed an atherogenic diet, with or without injections of RS-2982 for 3 weeks; livers were analyzed by immunohistochemistry, and plasma was analyzed for levels of aminotransferases. We analyzed data from liver tissues from patients with NASH included in the RNA-sequencing databases GSE33814 and GSE89632., Results: Injection of mice with antagomiR-122 significantly reduced levels of MIR122 in plasma, liver, and white adipose tissue; in mice on an HFD, antagomiR-122 injections increased fat droplets and total triglyceride content in liver and reduced β-oxidation and energy expenditure, resulting in significantly more weight gain than in mice given the control microRNA. We identified RS-2982 as an agonist of RORA and found it to increase expression of MIR122 promoter activity in Huh7 cells. In mice fed an HFD or atherogenic diet, injections of RS-2982 increased hepatic levels of MIR122 precursors and reduced hepatic synthesis of triglycerides by reducing expression of biosynthesis enzymes. In these mice, RS-2982 significantly reduced hepatic lipotoxicity, reduced liver fibrosis, increased insulin resistance, and reduced body weight compared with mice injected with vehicle. Patients who underwent cardiovascular surgery had increased levels of plasma MIR122 compared to its levels before surgery; increased expression of plasma MIR122 was associated with increased levels of plasma free fatty acids and levels of RORA., Conclusions: We identified the compound RS-2982 as an agonist of RORA that increases expression of MIR122 in cell lines and livers of mice. Mice fed an HFD or atherogenic diet given injections of RS-2982 had reduced hepatic lipotoxicity, liver fibrosis, and body weight compared with mice given the vehicle. Agonists of RORA might be developed for treatment of NASH., (Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
36. Load cell torques and force data collection during tele-operated robotic gas tungsten arc welding in presence of collisions.
- Author
-
Tannous M, Bologna F, and Stefanini C
- Abstract
Torque and force signals data were acquired from a load-cell sensor during a robotic welding process, in presence of collisions between the tool and the workpiece edges outlined in part in "Haptic-based touch detection for collaborative robots in welding applications" [1]. The dataset is composed from 15 tests captured during a tele-operated welding robot performing a 1G ASME/AWS (i.e., PA ISO) welding process. The raw data files have been provided. These data can be used to correlate torque signal features with collision events, to improve algorithms of collision detection/avoidance and to develop reliable real-time haptic feedback to the welder. This dataset can also be used to study the torque signal variation in different welding positions (e.g., 2G, 3G, 2F, etc.). Dataset is provided as raw data and in MATLAB files., Competing Interests: The authors financial interests or personal relationships which have, or could be perceived to have, influenced the work reported in declare that they have no known competing this article., (© 2020 The Author(s).)
- Published
- 2020
- Full Text
- View/download PDF
37. History of Cyclodextrin Nanosponges.
- Author
-
Krabicová I, Appleton SL, Tannous M, Hoti G, Caldera F, Rubin Pedrazzo A, Cecone C, Cavalli R, and Trotta F
- Abstract
Nowadays, research in the field of nanotechnology and nanomedicine has become increasingly predominant, focusing on the manipulation and development of materials on a nanometer scale. Polysaccharides have often been used as they are safe, non-toxic, hydrophilic, biodegradable and are low cost. Among them, starch derivatives and, in particular, cyclodextrin-based nanosponges (CD NSs) have recently emerged due to the outstanding properties attributable to their peculiar structure. In fact, alongside the common polysaccharide features, such as the presence of tunable functional groups and their ability to interact with biological tissues, thus giving rise to bioadhesion, which is particularly useful in drug delivery, what makes CD NSs unique is their three-dimensional network made up of crosslinked cyclodextrin units. The name "nanosponge" appeared for the first time in the 1990s due to their nanoporous, sponge-like structure and responded to the need to overcome the limitations of native cyclodextrins (CDs), particularly their water solubility and inability to encapsulate charged and large molecules efficiently. Since CD NSs were introduced, efforts have been made over the years to understand their mechanism of action and their capability to host molecules with low or high molecular weight, charged, hydrophobic or hydrophilic by changing the type of cyclodextrin, crosslinker and degree of crosslinking used. They enabled great advances to be made in various fields such as agroscience, pharmaceutical, biomedical and biotechnological sectors, and NS research is far from reaching its conclusion. This review gives an overview of CD NS research, focusing on the origin and key points of the historical development in the last 50 years, progressing from relatively simple crosslinked networks in the 1960s to today's multifunctional polymers. The approach adopted in writing the present study consisted in exploring the historical evolution of NSs in order to understand their role today, and imagine their future.
- Published
- 2020
- Full Text
- View/download PDF
38. Nanosponges for combination drug therapy: state-of-the-art and future directions.
- Author
-
Tannous M, Trotta F, and Cavalli R
- Subjects
- Drug Therapy, Combination, Cyclodextrins, Drug Delivery Systems, Nanostructures
- Published
- 2020
- Full Text
- View/download PDF
39. Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.
- Author
-
Teng J, Hejazi S, Hiddingh L, Carvalho L, de Gooijer MC, Wakimoto H, Barazas M, Tannous M, Chi AS, Noske DP, Wesseling P, Wurdinger T, Batchelor TT, and Tannous BA
- Subjects
- Animals, Antineoplastic Agents, Alkylating pharmacology, Apoptosis, Brain Neoplasms classification, Brain Neoplasms genetics, Brain Neoplasms pathology, Cell Proliferation, Drug Repositioning, Glioblastoma classification, Glioblastoma genetics, Glioblastoma pathology, Humans, Mice, Nucleic Acid Synthesis Inhibitors pharmacology, Tumor Cells, Cultured, Xenograft Model Antitumor Assays, Brain Neoplasms drug therapy, DNA Replication drug effects, Drug Evaluation, Preclinical, Drug Resistance, Neoplasm drug effects, Glioblastoma drug therapy, Hydroxyurea pharmacology, Temozolomide pharmacology
- Abstract
Background: Glioblastoma (GBM) is the most common and most aggressive primary malignant brain tumor. Standard-of-care treatment involves maximal surgical resection of the tumor followed by radiation and chemotherapy (temozolomide [TMZ]). The 5-year survival rate of patients with GBM is <10%, a colossal failure that has been partially attributed to intrinsic and/or acquired resistance to TMZ through O6-methylguanine DNA methyltransferase (MGMT) promoter methylation status in the tumor., Methods: A drug screening aimed at evaluating the potential recycling and repurposing of known drugs was conducted in TMZ-resistant GBM cell lines and primary cultures of newly diagnosed GBM with different MGMT promoter methylation status, phenotypic/genotypic background and subtype, and validated with sphere formation, cell migration assays, and quantitative invasive orthotopic in vivo models., Results: We identified hydroxyurea (HU) to synergize with TMZ in GBM cells in culture and in vivo, irrespective of MGMT promoter methylation status, subtype, and/or stemness. HU acts specifically on the S-phase of the cell cycle by inhibiting the M2 unit of enzyme ribonucleotide reductase. Knockdown of this enzyme using RNA interference and other known chemical inhibitors exerted a similar effect to HU in combination with TMZ both in culture and in vivo., Conclusions: We demonstrate preclinical efficacy of repurposing hydroxyurea in combination with TMZ for adjuvant GBM therapy. This combination benefit is of direct clinical interest given the extensive use of TMZ and the associated problems with TMZ-related resistance and treatment failure.
- Published
- 2018
- Full Text
- View/download PDF
40. Evolution of Cyclodextrin Nanosponges.
- Author
-
Caldera F, Tannous M, Cavalli R, Zanetti M, and Trotta F
- Subjects
- Hydrogen-Ion Concentration, Polymers, Temperature, Cyclodextrins chemistry, Drug Delivery Systems, Nanoparticles chemistry
- Abstract
Cyclodextrin-based nanosponges (CD-NSs) are insoluble, highly cross-linked 3D network polymers used in several scientific and technological fields, the main area of investigation concerns the pharmaceutical applications, in which CD-NSs have been mostly employed as drug delivery systems. CD-NSs can be generally grouped into four consecutive generations, taking into account their chemical composition and properties. The 1st generation of NSs are plain nanosponges, subdivided into four main types: urethane, carbonate, ester and ether NSs, depending on the chemical nature of the functional group connecting the CD to the cross-linker. The 2nd generation of NSs are modified nanosponges characterized by specific properties, such as fluorescence and electric charge. The 3rd generation of NSs is represented by stimuli-responsive CD polymers, which are able to modulate their behavior according to external variations in the environment, such as pH and temperature gradients, oxidative/reducing conditions, and finally the 4th generation of NSs, a new family of molecularly imprinted CD polymers (MIPs), exhibiting a high selectivity towards specific molecules. The following review focuses on the evolution of cyclodextrin nanosponges, listing some examples of each generation., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
41. Gaussia luciferase-based mycoplasma detection assay in mammalian cell culture.
- Author
-
Degeling MH, Bovenberg MS, Tannous M, and Tannous BA
- Subjects
- Animals, Copepoda genetics, Culture Media, HEK293 Cells, Humans, Luciferases genetics, Luciferases isolation & purification, Recombinant Proteins genetics, Recombinant Proteins isolation & purification, Recombinant Proteins metabolism, Biosensing Techniques methods, Copepoda enzymology, Luciferases metabolism, Luminescent Measurements methods, Mycoplasma isolation & purification
- Abstract
Mycoplasma contamination in mammalian cell culture is a common problem with serious consequences on experimental data, and yet many laboratories fail to perform regular testing. In this chapter, we describe a simple and sensitive mycoplasma detection assay based on the bioluminescent properties of the Gaussia luciferase reporter.
- Published
- 2014
- Full Text
- View/download PDF
42. Multiplex blood reporters for simultaneous monitoring of cellular processes.
- Author
-
Bovenberg MS, Degeling MH, Hejazi S, Amante RJ, van Keulen M, Jeuken JW, Akbaripanahi S, Vleggeert-Lankamp CL, Tannous M, Wesseling P, Wurdinger T, and Tannous BA
- Subjects
- Animals, Cell Line, Tumor, Humans, Mice, Mice, Nude, Blood, Luciferases blood
- Abstract
Reporters secreted into the conditioned medium of cells in culture or into blood in vivo have shown to be useful tools for simple and noninvasive monitoring of biological processes in real-time. Here, we characterize the naturally secreted Vargula luciferase as a secreted blood reporter and show that this reporter can be multiplexed with the secreted Gaussia luciferase and alkaline phosphatase for simultaneous monitoring of three different cellular processes in the same biological system. We applied this system to monitor the response of three different subsets of glioma cells to a clinically relevant chemotherapeutic agent in the same well in culture or animal in vivo. This system could be extended to any field to detect multiple processes in the same biological system and is amenable for high-throughput screening to find drugs that affect multiple cellular populations/phenomena simultaneously.
- Published
- 2013
- Full Text
- View/download PDF
43. Forced expression of OCT4 influences the expression of pluripotent genes in human mesenchymal stem cells and fibroblasts.
- Author
-
Palma CS, Tannous MA, Malta TM, Russo EM, Covas DT, and Picanço-Castro V
- Subjects
- Cell Line, Tumor, Cells, Cultured, Gene Expression Profiling, Humans, Kruppel-Like Factor 4, Octamer Transcription Factor-3 metabolism, Transduction, Genetic, Fibroblasts metabolism, Gene Expression, Mesenchymal Stem Cells metabolism, Octamer Transcription Factor-3 genetics
- Abstract
Genetic reprogramming of adult cells to generate induced pluripotent stem (iPS) cells is a new and important step in sidestepping some of the ethical issues and risks involved in the use of embryonic stem cells. iPS cells can be generated by introduction of transcription factors, such as OCT4, SOX2, KLF4, and CMYC. iPS cells resemble embryonic stem cells in their properties and differentiation potential. The mechanisms that lead to induced pluripotency and the effect of each transcription factor are not completely understood. We performed a critical evaluation of the effect of overexpressing OCT4 in mesenchymal stem cells and fibroblasts and found that OCT4 can activate the expression of other stemness genes, such as SOX2, NANOG, CMYC, FOXD3, KLF4, and βCATENIN, which are not normally or are very weakly expressed in mesenchymal stem cells. Transient expression of OCT4 was also performed to evaluate whether these genes are affected by its overexpression in the first 48 h. Transfected fibroblast cells expressed around 275-fold more OCT4 than non-transfected cells. In transient expression, in which cells were analyzed after 48 h, we detected only the up-regulation of FOXD3, SOX2, and KLF4 genes, suggesting that these genes are the earlier targets of OCT4 in this cellular type. We conclude that forced expression of OCT4 can alter cell status and activate the pluripotent network. Knowledge gained through study of these systems may help us to understand the kinetics and mechanism of cell reprogramming.
- Published
- 2013
- Full Text
- View/download PDF
44. Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability.
- Author
-
Degeling MH, Bovenberg MS, Lewandrowski GK, de Gooijer MC, Vleggeert-Lankamp CL, Tannous M, Maguire CA, and Tannous BA
- Subjects
- Amino Acid Sequence, Luciferases chemistry, Molecular Sequence Data, Directed Molecular Evolution, Light, Luciferases genetics, Luciferases metabolism, Luminescent Measurements, Mutation
- Abstract
Gaussia Luciferase (Gluc) has proven to be a powerful mammalian cell reporter for monitoring numerous biological processes in immunology, virology, oncology, and neuroscience. Current limitations of Gluc as a reporter include its emission of blue light, which is absorbed by mammalian tissues, limiting its use in vivo, and a flash-type bioluminescence reaction, making it unsuited for high-throughput applications. To overcome these limitations, a library of Gluc variants was generated using directed molecular evolution and screened for relative light output, a shift in emission spectrum, and glow-type light emission kinetics. Several variants with a 10-15 nm shift in their light emission peak were found. Further, a Gluc variant that catalyzes a glow-type bioluminescence reaction, suited for high-throughput applications, was also identified. These results indicate that molecular evolution could be used to modulate Gluc bioluminescence reaction characteristics.
- Published
- 2013
- Full Text
- View/download PDF
45. [Gallbladder polyps: Clinical and pathological features in Cholecystectomy patients in the Anglo American clinic in the period of 1999-2007].
- Author
-
Bugosen Tannous M, Tagle Arróspide M, Huerta-Mercado Tenorio J, and Scavino Levy Y
- Subjects
- Adolescent, Adult, Aged, Female, Hospitals, Humans, Male, Middle Aged, Retrospective Studies, Time Factors, Young Adult, Cholecystectomy, Gallbladder Diseases diagnosis, Gallbladder Diseases surgery, Polyps diagnosis, Polyps surgery
- Abstract
Objective: To describe the clinical and anatomopathologic characteristics of gallbladder polyps found in patients who underwent cholecystectomy at Clinica Anglo Americana for the 1999-2007 period., Materials and Methods: Descriptive and retrospective study that started at Pathology Department where patients with anatomopathologic finding of gallbladder polyps who underwent cholecystectomy for the 1999-2007 period were selected. Clinical records were reviewed to take ultrasonographic, anatomopathologic and clinical characteristics, which were included and studied in a data base in Microsoft Excel., Results: Gallbladder polyps were found in 172 (10%) of 1707 gallbladders that were analized. Cholesterolosic polyps were found in 95.4% of the cases, 4% were adenomas and 0.6% were hyperplasic polyps. Gallbladder polyps ≥ 10 mm were found in 32,25% of the cases. A 90% of these polyps were cholesterolosic and a 10% were adenomas. No malign polyps were found in this study., Conclusions: The vast majority of gallbladder polyps, including the ≥ 10 mm group, were cholesterolosic. The physician decision to remove the gallbladder must be individualized and discussed with each patient, considering gallbladder polyp characteristics such as size and growth rate of the lesion.
- Published
- 2011
46. Essential role for membrane lipid rafts in interleukin-1beta-induced nitric oxide release from insulin-secreting cells: potential regulation by caveolin-1+.
- Author
-
Veluthakal R, Chvyrkova I, Tannous M, McDonald P, Amin R, Hadden T, Thurmond DC, Quon MJ, and Kowluru A
- Subjects
- Animals, Cell Line, Gene Expression Regulation physiology, Genes, ras, Male, Protein-Tyrosine Kinases antagonists & inhibitors, Rats, Rats, Sprague-Dawley, Signal Transduction, Interleukin-1 physiology, Islets of Langerhans physiology, Membrane Microdomains physiology, Nitric Oxide metabolism
- Abstract
We recently reported that the activation of H-Ras represents one of the signaling steps underlying the interleukin-1beta (IL-1beta)-mediated metabolic dysfunction of the islet beta-cell. In the present study, we examined potential contributory roles of membrane-associated, cholesterol-enriched lipid rafts/caveolae and their constituent proteins (e.g., caveolin-1 [Cav-1]) as potential sites for IL-1beta-induced nitric oxide (NO) release in the isolated beta-cell. Disruption of lipid rafts (e.g., with cyclodextrin) markedly reduced IL-1beta-induced gene expression of inducible NO synthase (iNOS) and NO release from beta-cells. Immunologic and confocal microscopic evidence also suggested a transient but significant stimulation of tyrosine phosphorylation of Cav-1 in beta-cells briefly (for 15 min) exposed to IL-1beta that was markedly attenuated by three structurally distinct inhibitors of protein tyrosine phosphorylation. Overexpression of an inactive mutant of Cav-1 lacking the tyrosine phosphorylation site (Y14F) or an siRNA-mediated Cav-1 knock down also resulted in marked attenuation of IL-1beta-induced iNOS gene expression and NO release from these cells, thus further implicating Cav-1 in this signaling cascade. IL-1beta treatment also increased (within 20 min) the translocation of H-Ras into lipid rafts. Here we provide the first evidence to suggest that tyrosine phosphorylation of Cav-1 and subsequent interaction among members of the Ras signaling pathway within the membrane lipid microdomains represent early signaling mechanisms of IL-1beta in beta-cells.
- Published
- 2005
- Full Text
- View/download PDF
47. Novel roles for palmitoylation of Ras in IL-1 beta-induced nitric oxide release and caspase 3 activation in insulin-secreting beta cells.
- Author
-
Chen HQ, Tannous M, Veluthakal R, Amin R, and Kowluru A
- Subjects
- Acylation, Antifungal Agents pharmacology, Caspase 3, Cells, Cultured, Cerulenin pharmacology, Humans, Insulin metabolism, Insulin Secretion, Islets of Langerhans metabolism, Methylation, Oxidation-Reduction, ras Proteins metabolism, Caspases metabolism, Interleukin-1 pharmacology, Islets of Langerhans drug effects, Nitric Oxide metabolism, Palmitates metabolism, ras Proteins physiology
- Abstract
We recently demonstrated that functional inactivation of H-Ras results in significant reduction in interleukin 1 beta (IL-1 beta)-mediated effects on isolated beta cells. Since palmitoylation of Ras has been implicated in its membrane targeting, we examined the contributory roles of palmitoylation of Ras in IL-1 beta-induced nitric oxide (NO) release and subsequent activation of caspases. Preincubation of HIT-T15 or INS-1 cells with cerulenin (CER, 134 microM; 3 hr), an inhibitor of protein palmitoylation, significantly reduced (-95%) IL-1 beta-induced NO release from these cells. 2-Bromopalmitate, a structurally distinct inhibitor of protein palmitoylation, but not 2-hydroxymyristic acid, an inhibitor of protein myristoylation, also reduced (-67%) IL-1 beta-induced NO release from HIT cells. IL-induced inducible nitric oxide synthase gene expression was markedly attenuated by CER. Further, CER markedly reduced incorporation of [3H]palmitate into H-Ras and caused significant accumulation of Ras in the cytosolic fraction. CER-treatment also prevented IL-1 beta-induced activation of caspase 3 in these cells. Moreover, N-monomethyl-L-arginine, a known inhibitor of inducible nitric oxide synthase, markedly inhibited IL-induced activation of caspase 3, thus establishing a link between IL-induced NO release and caspase 3 activation. Depletion of membrane-bound cholesterol using methyl-beta-cyclodextrin, which also disrupts caveolar organization within the plasma membrane, abolished IL-1 beta-induced NO release suggesting that IL-1 beta-mediated Ras-dependent signaling in these cells involves the intermediacy of caveolae and their key constituents (e.g. caveolin-1) in isolated beta cells. Confocal light microscopic evidence indicated significant colocalization of Ras with caveolin-1. Taken together, our data provide the first evidence to indicate that palmitoylation of Ras is essential for IL-1 beta-induced cytotoxic effects on the islet beta cell.
- Published
- 2003
- Full Text
- View/download PDF
48. Novel roles for the rho subfamily of GTP-binding proteins in succinate-induced insulin secretion from betaTC3 cells: further evidence in support of the succinate mechanism of insulin release.
- Author
-
Kowluru A, Chen HQ, and Tannous M
- Subjects
- Animals, Bacterial Toxins pharmacology, Cell Line, Cytotoxins pharmacology, Imidazoles pharmacology, Insulin Secretion, Islets of Langerhans cytology, Islets of Langerhans drug effects, Leucine pharmacology, Mitochondria metabolism, Rats, Succinic Acid antagonists & inhibitors, cdc42 GTP-Binding Protein metabolism, rac GTP-Binding Proteins metabolism, Bacterial Proteins, Insulin metabolism, Islets of Langerhans metabolism, Leucine analogs & derivatives, Succinic Acid pharmacology, rho GTP-Binding Proteins metabolism
- Abstract
We have previously demonstrated regulatory roles for Rho subfamily of G-proteins in glucose- and calcium-induced insulin secretion. Herein, we examined regulation by these proteins of insulin secretion from betaTC3 cells elicited by mitochondrial fuels, such as the succinic acid methyl ester (SAME). Preincubation of these cells with Clostridium difficile toxin-B (200 ng/mL), which monoglucosylates and inactivates Cdc42 and Rac1, markedly decreased (> 70%) SAME-induced insulin secretion. Furthermore, exposure of betaTC3 cells to GGTI-2147 (20 microM), a selective inhibitor of the requisite prenylation of Rac1 and Cdc42, significantly reduced (> 80%) SAME-induced insulin release, suggesting that post-translational prenylation of these proteins is necessary for SAME-induced insulin release. Western blot analysis indicated localization of Cdc42, Rac1, and Ras in the beta cell mitochondrial fraction. Confocal microscopy revealed a modest, but inconsistent, increase in the association of either Rac1 or Cdc42 with Mitotracker, a mitochondrial marker, following exposure to SAME. These data suggest that activation of preexisting intramitochondrial Rac1 and Cdc42 may be sufficient to regulate SAME-induced insulin secretion. Together, our findings support a role for G-proteins in insulin secretion at a step dependent on mitochondrial metabolism. They also identify mevalonate-derived, isoprenoid modified Rho G-proteins as specific signaling molecules in recently proposed succinate mechanism of insulin release.
- Published
- 2003
- Full Text
- View/download PDF
49. IL-1beta-induced nitric oxide release from insulin-secreting beta-cells: further evidence for the involvement of GTP-binding proteins.
- Author
-
Tannous M, Veluthakal R, Amin R, and Kowluru A
- Subjects
- Animals, Cells, Cultured, GTP-Binding Proteins drug effects, Islets of Langerhans drug effects, Kinetics, Rats, Rats, Sprague-Dawley, Tumor Cells, Cultured, GTP-Binding Proteins metabolism, Interleukin-1 pharmacology, Islets of Langerhans metabolism, Nitric Oxide metabolism
- Abstract
Recently, we have demonstrated regulatory roles for G-proteins (e.g., H-Ras) in IL-1beta induced NO release from HIT-T15 cells. Herein, we report a similar regulatory mechanism for IL-1beta induced NO release from RIN5F and INS-1 cells. Our data indicate that functional inactivation of Ras, either by Clostridial toxins or by specific inhibitors of Ras function, results in a significant inhibition in IL-1beta induced NO release, suggesting that activation of specific G-proteins is essential for IL-1beta induced NO release. In the present study, we report possible loci where IL-1beta treatment might result in functional activation of these G-proteins. For example, IL-1beta treatment resulted in significant reduction in (high-and low-affinity) GTPase activities in lysates derived from normal rat islets; such a scenario might lead to retention of candidate G-proteins in GTP-bound, active conformation. Further, IL-1beta treatment increased the G-protein carboxyl methyl transferase activity as well as carboxyl methylation of endogenous beta-cell proteins; such a modification has been shown to increase the membrane association and interaction of these G-proteins with their respective effector proteins. Also, we report immunologic localization of H-Ras regulatory proteins including its nucleotide exchange factor (GRF-1) and its effector protein (eg., Raf-1) in isolated beta-cells. Together, our data indicate localization, and regulation by IL-1beta, of specific enzymes that are critical to activation of G-proteins. Based on these preliminary findings, we propose a model for the involvement of G-proteins in IL-1beta induced NO release and subsequent demise of the pancreatic beta-cell.
- Published
- 2002
50. Inhibition of glucose- and calcium-induced insulin secretion from betaTC3 cells by novel inhibitors of protein isoprenylation.
- Author
-
Amin R, Chen HQ, Tannous M, Gibbs R, and Kowluru A
- Subjects
- Animals, Cell Line, Cell Survival drug effects, GTP-Binding Proteins metabolism, Guanosine Triphosphate metabolism, Insulin Secretion, Islets of Langerhans drug effects, Kinetics, Leucine analogs & derivatives, Polyenes pharmacology, Polyunsaturated Alkamides, Potassium Chloride pharmacology, Rats, Alkyl and Aryl Transferases antagonists & inhibitors, Calcium pharmacology, Enzyme Inhibitors pharmacology, Glucose pharmacology, Imidazoles pharmacology, Insulin metabolism, Islets of Langerhans metabolism, Leucine pharmacology, Protein Prenylation drug effects
- Abstract
The majority of low molecular weight G proteins undergoes a series of post-translational modification steps, e.g., isoprenylation, at their C-terminal cysteine, which seem to be critical for the transport of the modified proteins to the membrane sites for interaction with their respective effector proteins. Using lovastatin, an inhibitor of mevalonic acid, and hence, isoprenoid biosynthesis, we demonstrated previously that protein isoprenylation is critical for physiological insulin secretion from normal rat islets. Herein, we used more selective synthetic inhibitors of protein prenylation to examine their effects on glucose- and calcium-mediated insulin secretion from betaTC3 cells. Both 3-allyl- and vinylfarnesols, which inhibit and/or modulate protein farnesyl transferases, significantly (80-95%) inhibited glucose- and KCl-stimulated insulin secretion from these cells. In a similar manner, the allyl and vinyl forms of geranylgeraniol, reagents targeted toward protein geranylation, attenuated insulin secretion elicited by glucose and KCl. Furthermore, manumycin A, a natural inhibitor of protein farnesylation, and geranylgeranyl transferase inhibitor-2147 (GGTI-2147), a peptidomimetic inhibitor of protein geranylgeranylation, also inhibited glucose- and KCl-induced insulin secretion to comparable degrees. Treatment of betaTC3 cells with either 3-vinylfarnesol or 3-vinyl geranylgeraniol resulted in accumulation of unprenylated proteins in the cytosolic fraction. These data further support our original formulation that inhibition of isoprenylation of small molecular weight G proteins might impede their interaction with their putative effectors, which may be required for physiological insulin secretion.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.